{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:40:56Z","timestamp":1791196856356,"version":"4.1.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,6]],"date-time":"2011-10-06T00:00:00Z","timestamp":1317859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0025744","type":"journal-article","created":{"date-parts":[[2011,10,6]],"date-time":"2011-10-06T21:59:14Z","timestamp":1317938354000},"page":"e25744","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome\u00ae or Fungizone\u2122"],"prefix":"10.1371","volume":"6","author":[{"given":"Jagdishbhai L.","family":"Italia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine C.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Warn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N. V. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1469-0691.2009.02929.x","article-title":"Trends in invasive fungal infections, with emphasis on invasive aspergillosis.","volume":"15","author":"Z Erjavec","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adulthematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.","volume":"48","author":"D Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.","volume":"50","author":"JC Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2010.06.018","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.","volume":"61","author":"T Lehrnbecher","year":"2010","journal-title":"J Infect"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.","volume":"22","author":"TR Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation:outcomes and prognostic factors associated with mortality.","volume":"44","author":"A Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis.","volume":"10","author":"J van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/tropej\/fmp132","article-title":"Amphotericin B Therapy in Children with Visceral Leishmaniasis: Daily vs. Alternate Day, a Randomized Trial.","volume":"56","author":"UK Singh","year":"2010","journal-title":"J Trop Pediatr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/bmt.2009.325","article-title":"Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.","volume":"45","author":"SS Egger","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome of invasive aspergillosis.","volume":"23","author":"DW Denning","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref11","first-page":"625","article-title":"Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients.","volume":"63","author":"C Annaloro","year":"2009","journal-title":"J AntimicrobChemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(02)00686-5","article-title":"Formulation of amphotericin B as nanosuspension for oral administration.","volume":"254","author":"O Kayser","year":"2003","journal-title":"Int J Pharm"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.46.8.2704-2707.2002","article-title":"Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis.","volume":"46","author":"G Delmas","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2009.01.003","article-title":"Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.","volume":"372","author":"EK Wasan","year":"2009","journal-title":"Int J Pharm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","article-title":"Biodegradable nanoparticles improve oral bioavailability of Amphotericin B and shows reduced nephrotoxicity against intravenous Fungizone\u00ae.","volume":"26","author":"JL Italia","year":"2009","journal-title":"Pharm Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0032-5910(99)00182-5","article-title":"Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles.","volume":"107","author":"H Murakamia","year":"2000","journal-title":"Powder Tech"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1208\/pt030432","article-title":"The effect of cosolvents on the formulation of nanoparticles from low molecular-weight poly(l)lactide.","volume":"3","author":"L Peltonen","year":"2002","journal-title":"AAPS Pharm Sci Tech"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1021\/jp0446480","article-title":"Preferential solvation stabilization for hydrophobic polymeric nanoparticle fabrication.","volume":"109","author":"JY Xiong","year":"2005","journal-title":"J Phys Chem B"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1023\/B:PHAM.0000036917.75634.be","article-title":"Physicochemical parameters associated with nanoparticles formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods.","volume":"21","author":"S Galindo-Rodriguez","year":"2004","journal-title":"Pharm Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/03639040601077349","article-title":"Assessing the antifungal activity of a new oral lipid-based amphotericin B formulation following administration to rats infected with Aspergillus fumigatus.","volume":"33","author":"V Risovic","year":"2007","journal-title":"Drug Dev Ind Pharm"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(98)00039-8","article-title":"Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.","volume":"34","author":"E All\u00e9mann","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11095-005-8418-y","article-title":"Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.","volume":"23","author":"S Hariharan","year":"2005","journal-title":"Pharm Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1166\/jbn.2005.033","article-title":"Pharmaceutical aspects of polymeric nanoparticles for oral delivery.","volume":"1","author":"V Bhardwaj","year":"2005","journal-title":"J Biomed Nanotech"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/AAC.00787-06","article-title":"Standardization of an experimental murine model of invasive pulmonary aspergillosis.","volume":"50","author":"DC Sheppard","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijantimicag.2009.09.029","article-title":"Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.","volume":"35","author":"PA Warn","year":"2010","journal-title":"Int J Antimicrob Agents"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0025744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T15:29:43Z","timestamp":1540222183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0025744"}},"subtitle":[],"editor":[{"given":"Dimitris","family":"Fatouros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,6]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0025744","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,6]]}}}